Literature DB >> 16959051

Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodies.

R Ishak1, A C R Vallinoto, V N Azevedo, A C P Vicente, W W Hall, M O G Ishak.   

Abstract

Previous serological studies on the Arara do Laranjal Indian group revealed extensive HTLV-2 infections. A collection of 97 new samples from the Arara were found repeatedly negative using three different commercial enzyme immunoassays. Eight samples that exhibited optical density readings close to the cut-off value were re-evaluated using Western blot (GeneLab 2.4, Singapore) assay. One sample was found to be non-reactive, five exhibited indeterminate patterns, one was classified as HTLV, and one was confirmed as HTLV-2. Peripheral blood mononuclear cell DNA of the eight samples were subjected to nested PCR and restriction fragment length polymorphism (RFLP) analysis of the pX and env regions, and nucleotide sequencing of the 5'-LTR region. All produced amplification products of pX, but env could be amplified in only one sample with the commonly used primers. RFLP analysis of the pX region using TaqI confirmed HTLV-2 infection. Nucleotide sequencing of the 5'-LTR region was performed in three samples (HTLV-2, HTLV and indeterminate based on Western blot pattern). Phylogenetic analysis of a 449-nt fragment using the Neighbour-Joining method clearly demonstrated that the three samples clustered within the HTLV-2c molecular subtype. The present study confirms the wide dissemination of the HTLV-2c subtype among linguistically and culturally distinct Amazonian Indian groups, and emphasizes the unique occurrence of infection by this subtype in Brazil. Moreover, it emphasizes the limitation of employing the present serological screening assays in blood banks, epidemiological studies, and the importance of molecular assays in the confirmatory procedures for the primary detection of HTLV-2 infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959051      PMCID: PMC2870598          DOI: 10.1017/S0950268806006984

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Molecular evidence of mother-to-child transmission of HTLV-IIc in the Kararao Village (Kayapo) in the Amazon region of Brazil.

Authors:  R Ishak; A C Vallinoto; V N Azevedo; M Lewis; W W Hall; M O Guimarães Ishak
Journal:  Rev Soc Bras Med Trop       Date:  2001 Nov-Dec       Impact factor: 1.581

2.  Peopling of Andean South America.

Authors:  F Rothhammer; C Silva
Journal:  Am J Phys Anthropol       Date:  1989-03       Impact factor: 2.868

3.  Evidence for sexual transmission of human T lymphotropic virus type II.

Authors:  B Hjelle; S Cyrus; S G Swenson
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

4.  HTLV-II endemicity among Guaymi Indians in Panama.

Authors:  W Heneine; J E Kaplan; F Gracia; R Lal; B Roberts; P H Levine; W C Reeves
Journal:  N Engl J Med       Date:  1991-02-21       Impact factor: 91.245

5.  Simultaneous editing of multiple nucleic acid and protein sequences with ESEE.

Authors:  E L Cabot; A T Beckenbach
Journal:  Comput Appl Biosci       Date:  1989-07

6.  HTLV-II infection in Florida Indians.

Authors:  P H Levine; S Jacobson; R Elliott; A Cavallero; G Colclough; C Dorry; C Stephenson; R M Knigge; J Drummond; M Nishimura
Journal:  AIDS Res Hum Retroviruses       Date:  1993-02       Impact factor: 2.205

7.  Endemic HTLV-II infection among Tobas and Matacos Amerindians from north Argentina.

Authors:  M Biglione; A Gessain; S Quiruelas; O Fay; M A Taborda; E Fernandez; S Lupo; A Panzita; G de The
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-06

8.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.

Authors:  N Eiraku; P Novoa; M da Costa Ferreira; C Monken; R Ishak; O da Costa Ferreira; S W Zhu; R Lorenco; M Ishak; V Azvedo; J Guerreiro; M P de Oliveira; P Loureiro; N Hammerschlak; S Ijichi; W M Hall
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of 'nested' PCR products.

Authors:  P W Tuke; P Luton; J A Garson
Journal:  J Virol Methods       Date:  1992-11       Impact factor: 2.014

10.  Multiple isolates and characteristics of human T-cell leukemia virus type II.

Authors:  W W Hall; H Takahashi; C Liu; M H Kaplan; O Scheewind; S Ijichi; K Nagashima; R C Gallo
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  8 in total

1.  A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Authors:  Claudia Filippone; Sylviane Bassot; Edouard Betsem; Patricia Tortevoye; Micheline Guillotte; Odile Mercereau-Puijalon; Sabine Plancoulaine; Sara Calattini; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Bioprospection and Selection of Peptides by Phage Display as Novel Epitope-Based Diagnostic Probes for Serological Detection of HTLV-1 and Use in Future Vaccines.

Authors:  Luiz Fernando Almeida Machado; Luiz Ricardo Goulart Filho; Fabiana Almeida Araújo Santos; Leonardo Quintão Siravenha; Andrea Nazaré Monteiro Rangel Silva; Maria Alice Freitas Queiroz; Antonio Carlos Rosário Vallinoto; Marluísa Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Front Med (Lausanne)       Date:  2022-06-09

3.  Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination.

Authors:  Britta Moens; Giovanni López; Vanessa Adaui; Elsa González; Lien Kerremans; Daniel Clark; Kristien Verdonck; Eduardo Gotuzzo; Guido Vanham; Olivier Cassar; Antoine Gessain; Anne-Mieke Vandamme; Sonia Van Dooren
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

4.  Human T-lymphotropic virus 1 and 2 among people who used illicit drugs in the state of Pará, northern Brazil.

Authors:  Aldemir B Oliveira-Filho; Ana Paula S Araújo; Andreia Polliana C Souza; Camila M Gomes; Gláucia C Silva-Oliveira; Luísa C Martins; Benedikt Fischer; Luiz Fernando A Machado; Antonio Carlos R Vallinoto; Ricardo Ishak; José Alexandre R Lemos; Emil Kupek
Journal:  Sci Rep       Date:  2019-10-14       Impact factor: 4.379

5.  Isolation of the Arawete and Asurini Indians keeps the tribes free from HTLV infection during 36 years of follow-up.

Authors:  Antonio C R Vallinoto; Mateus I Otake; Paulo V N R Sousa; Felipe T Lopes; Eliene R P Sacuena; Maria A F Queiroz; Greice L C Costa; Marluísa O G Ishak; Izaura M V Cayres-Vallinoto; João F Guerreiro; Ricardo Ishak
Journal:  Retrovirology       Date:  2019-10-22       Impact factor: 4.602

6.  Line Immunoassay for Confirmation and Discrimination of Human T-Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil.

Authors:  Karoline R Campos; Fred L N Santos; Bernardo Galvão-Castro; Adele Caterino-de-Araujo; Vanessa da Silva Brito; Noilson L S Gonçalves; Thessika H A Araujo
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

7.  Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Authors:  Carolina Rosadas; Carlos Brites; Denise Arakaki-Sanchez; Jorge Casseb; Ricardo Ishak
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

8.  Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).

Authors:  Karoline Rodrigues Campos; Maria Gisele Gonçalves; Nadia Aparecida Costa; Adele Caterino-de-Araujo
Journal:  Braz J Infect Dis       Date:  2017-03-24       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.